Persistent allergic rhinitis as a factor causing and complicating the course of acute and chronic bacterial diseases of ENT organs

Allergic rhinitis (AR) is one of the global progressively growing problems of modern medicine. In different regions of the Russian Federation, the prevalence of AR ranges from 12 to 24%. Recent studies have shown an increase in the incidence of AR. Symptoms of rhinitis have a pronounced negative impact on the quality of life of patients. AR is not a mild harmless disease, but a harbinger and predisposing factor in the development of more severe, often disabling diseases. Over the past 4 years, new international guidelines for the diagnosis and treatment of AR have been developed, which have helped to significantly improve the management of patients with this nosology. A new concept of step-by-step therapy of AR based on the control of clinical symptoms of the disease has been created. Currently, over 150 names of antihistamines are registered in Russia. Due to the variety of antihistamines, it is quite difficult to make a choice between them for their most effective and rational use in specific clinical cases. In the treatment of patients with AR, it is necessary to use a personalized approach and select the optimal treatment for each patient based on the manifestations of the pathological process. Following the algorithm of AR therapy, depending on the severity of symptoms, II generation antihistamines should be prescribed as starting therapy to patients with any AR severity. II generation antihistamines used to treat AR are effective, safe and well tolerated.

allergic rhinitis, complications of allergic rhinitis, antihistamines, cetirizine